Target intelligence / Profile preview

Ribosomal protein L34 pseudogene 18 (RPL34P18)

Target
RPL34P18
Molecular classification
Pseudogene, Other
01

Overview

Ribosomal protein L34 pseudogene 18 (RPL34P18) is classified as a pseudogene, meaning it shares sequence similarity with the functional ribosomal protein L34 gene but is not transcribed into a functional protein[2][1][8]. Pseudogenes like RPL34P18 arise through duplication or retrotransposition events during evolution and generally do not produce active proteins or carry out the biological roles of their parent genes[5][2]. RPL34P18 is thus not considered a therapeutic target, receptor, enzyme, nor is it implicated in drug interaction or disease biomarker development. There are no functional or pharmacological data, and its designation as a target is incorrect due to its non-coding status[2][1][8].

Other names
RPL34_7_926RPL34P18
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, not functionally expressed)
04

Disease associations

Other (no direct disease association; lacks expression or function)

Beyond the preview

Go deeper on Ribosomal protein L34 pseudogene 18 (RPL34P18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L34 pseudogene 18 (RPL34P18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call